Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh
Chandigarh, 160012, India
NCT Number: NCT07712172
The goal of this observational study is to quantify activity and extent of disease in patients with GPA using 18F-FDG PET/CT. The main questions it aims to answer are:
Sensitivity of 18 F-FDG PET/CT in patients with GPA? Correlation of 18F-FDG PET/CT semi-quantitative parameters with BVAS v3?
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Chandigarh, 160012, India
Patients age more than 18 with active GPA were recruited and 18F-FDG PET/CT was done after clinical assessment and evaluation. BVAS v3 score was calculated and then patients underwent 18F-FDG PET/CT. Findings of the scans were evaluated by expert nuclear medicine physicians and various semiquantitative parameters were calculated. Sensitivity was then calculated and correlation of BVAS v3 score was done with the calculated semiquantitative parameters.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients with newly diagnosed or relapsed active GPA, Age more than or equal to18 years.
Exclusion criteria
Pregnant/ lactating women and non-consenting adults
18 F-FDG PET/CT was done for patients with active GPA
Use of 18F-FDG PET/CT scan in patients with active GPA
Time frame: Baseline
Post Graduate Institute of Medical Education and Research, Chandigarh
Other
Assessment of Disease Activity in Patients With Granulomatosis With Polyangiitis Using 18F-Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography and Its Correlation With Birmingham Vasculitis Activity Score Version 3
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02108860
ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Los Angeles, California, United States
View Trial DetailsNCT01241305
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Aortic Arch Syndromes
Los Angeles, California, United States
View Trial DetailsNCT02967068
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Aortic Arch Syndromes
Boston, Massachusetts, United States
View Trial DetailsNCT01167491
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases
Paris, France
View Trial Details